Andrew Willis

Andrew Willis is a Regulatory advisor with 33 years of experience with regulatory affairs and pharmaceutical development. He has experience at multiple levels within pharmaceutical companies and most recently as Vice President for Regulatory Affairs, gaining significant experience in co-ordinating, planning and running global development projects relating to orphan products and ATMPs.